Aqix is the world leader in synthetic interstitial fluid. Aqix RS-I, its lead product, keeps human tissues in the conditions of the body, because it is a replication of the conditions of the body. The result is the ability to keep vital tissues alive for long periods of time. It is currently used by leading pharmaceutical companies around the world in their human tissue research.
Aqix Limited is also developing the same technology for transplant and blood expansion uses.
Company Details
- Employees
- 6
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aqix.com
- Keywords
- Transplant, Cancer, Stem Cells, Perfusion, Blood, Biopsy.
Aqix Limited Questions
Aqix Limited's website is aqix.com
Aqix Limited's LinkedIn profile is https://uk.linkedin.com/company/aqix-limited
Aqix Limited has
6 employees.
View email and phone details for 6
employees at Aqix Limited.
Aqix Limited's industry is
Biotechnology Research
Aqix Limited's top competitors are
Alturix,
Beam Alliance,
Aquila Biolabs,
Spherobiotics,
Addex Therapeutics,
Analytic Health,
Acm Biosciences Ag,
Acm Biolabs,
Altacor,
Adc Bioscientific Ltd.
Aqix Limited's categories are Biotechnology Research
Aqix Limited's founding year is 1999
